{"brief_title": "A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients", "brief_summary": "To evaluate the efficacy, safety, and durability of response of SP-303 in decreasing stool weight in AIDS patients with diarrhea over 6 days of treatment.", "condition": "HIV Infections", "intervention_type": "Drug", "intervention_name": "Crofelemer", "criteria": "Inclusion Criteria Patients must have: - HIV infection meeting CDC criteria for AIDS. - History of diarrhea for greater than or equal to 14 days prior to screening period (Day 1). Required: - On stable medical regimen.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00002408.xml"}